Vitalex Biosciences, LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCoto De Caza, CA
SAM.gov UEIHHJ4JD7CEHZ5
Vitalex Biosciences is a pre-clinical-stage biotechnology startup developing treatments and diagnostics for infectious diseases, particularly fungal infections. Its pipeline includes VX-01, a monoclonal antibody targeting the CotH cell surface protein on Mucorales; VXV-01, a dual antigen vaccine for hospital-acquired infections caused by multidrug-resistant Candida albicans, Candida auris, and Gram-negative bacteria; and VXD-01, a rapid diagnostic test for Mucormycosis.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Vitalex Biosciences, LLC | Coto De Caza | CA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.